Biktarvy 30 mg/1
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate · TABLET · Gilead Sciences, Inc.
Biktarvy is a prescription tablet taken by mouth that contains three medications combined to treat HIV infection. It works by blocking the virus from reproducing in your body and is part of a class of drugs called nucleoside analog reverse transcriptase inhibitors.
Key Facts
- Brand Name
- Biktarvy
- Generic Name
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- NDC Code (Product)
61958-2505- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 30 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA210251
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 10/07/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Biktarvy used for?
Biktarvy is a prescription tablet taken by mouth that contains three medications combined to treat HIV infection. It works by blocking the virus from reproducing in your body and is part of a class of drugs called nucleoside analog reverse transcriptase inhibitors.
Is Biktarvy a controlled substance?
Biktarvy is not classified as a controlled substance by the DEA.
What is the generic name for Biktarvy?
The generic name for Biktarvy is bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate. There are no other listed brand versions of bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate.
What is the NDC code for Biktarvy 30 mg/1?
The NDC (National Drug Code) for Biktarvy 30 mg/1 is 61958-2505, listed by Gilead Sciences, Inc..
Other Biktarvy Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)